Published in Am J Obstet Gynecol on March 01, 2005
A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry (2010) 5.00
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol (2009) 3.52
Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ (2010) 2.67
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry (2009) 2.01
Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand (2012) 1.75
Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol (2007) 1.43
Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol (2009) 1.34
Reducing stillbirths: behavioural and nutritional interventions before and during pregnancy. BMC Pregnancy Childbirth (2009) 1.32
Depression in childbearing women: when depression complicates pregnancy. Prim Care (2009) 1.22
Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci (2008) 1.22
When depression complicates childbearing: guidelines for screening and treatment during antenatal and postpartum obstetric care. Obstet Gynecol Clin North Am (2009) 1.09
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy? Nicotine Tob Res (2009) 1.06
Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol (2013) 0.85
Perinatal depression: implications for child mental health. Ment Health Fam Med (2010) 0.84
Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. PLoS One (2012) 0.82
Uterine blood flow in a psychiatric population: impact of maternal depression, anxiety, and psychotropic medication. Biol Psychiatry (2012) 0.80
Prenatal tobacco prevention and cessation interventions for women in low- and middle-income countries. Acta Obstet Gynecol Scand (2010) 0.79
Prenatal antidepressant exposure: clinical and preclinical findings. Pharmacol Rev (2014) 0.79
The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse. Am J Drug Alcohol Abuse (2010) 0.78
Smoking cessation therapy during pregnancy. Can Fam Physician (2012) 0.78
The Smoking MUMS (Maternal Use of Medications and Safety) Study: protocol for a population-based cohort study using linked administrative data. BMJ Open (2013) 0.77
Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges. Drug Healthc Patient Saf (2014) 0.76
Paroxetine and neonatal withdrawal syndrome. BMJ Case Rep (2010) 0.76
Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation. Indian J Psychiatry (2015) 0.75
HIV-infected adolescent, young adult and pregnant smokers: important targets for effective tobacco control programs. Int J Environ Res Public Health (2013) 0.75
Diagnosing and Treating Depression During Pregnancy. Prim Care Companion CNS Disord (2015) 0.75
Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71
Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol (2013) 3.68
Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr (2011) 2.86
Variables associated with medication errors in pediatric emergency medicine. Pediatrics (2002) 2.86
Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can (2007) 2.64
Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther (2002) 2.53
Perinatal risks of untreated depression during pregnancy. Can J Psychiatry (2004) 2.50
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41
Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med (2002) 2.32
Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol (2012) 2.23
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22
Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf (2005) 2.21
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG (2004) 2.04
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol (2009) 2.03
FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? Can Fam Physician (2010) 2.02
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry (2008) 2.01
Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry (2005) 2.00
Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ (2005) 1.99
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther (2007) 1.98
Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest (2008) 1.93
Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther (2003) 1.91
Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit (2003) 1.91
Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med (2007) 1.91
Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry (2012) 1.88
Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician (2007) 1.83
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril (2006) 1.80
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells (2008) 1.78
Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology (2011) 1.78
Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med (2004) 1.77
Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can (2009) 1.76
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72
Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol (2007) 1.70
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry (2002) 1.68
Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967. Ther Drug Monit (2003) 1.68
The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.67
The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.66
Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65
Pregnancy outcome following non-obstetric surgical intervention. Am J Surg (2005) 1.65
Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg (2009) 1.65
More codeine fatalities after tonsillectomy in North American children. Pediatrics (2012) 1.63
A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England. Epilepsia (2002) 1.62
Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology (2005) 1.62
Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm (2012) 1.62
Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) (2013) 1.60
Pregnancy and isotretinoin therapy. CMAJ (2013) 1.60
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf (2002) 1.58
Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med (2009) 1.57
Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol (2002) 1.55
Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med (2003) 1.55
Hair mercury levels of women of reproductive age in Ontario, Canada: implications to fetal safety and fish consumption. J Pediatr (2010) 1.52
Breast-feeding during maternal use of azathioprine. Ann Pharmacother (2006) 1.52
A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]. BMC Pregnancy Childbirth (2006) 1.50
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm (2013) 1.50
Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother (2003) 1.48
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet (2011) 1.48
Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry (2014) 1.45
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44
Hair methylmercury: a new indication for therapeutic monitoring. Ther Drug Monit (2010) 1.44
Safety of the newer class of opioid antagonists in pregnancy. Can Fam Physician (2014) 1.43
Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol (2011) 1.43
Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) (2010) 1.43
Evaluation of drug formularies for pediatric intensive care. Pediatr Crit Care Med (2011) 1.42
Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol (2004) 1.42
Patterns of paediatric analgesic use in Africa: a systematic review. Arch Dis Child (2012) 1.42
Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? CMAJ (2005) 1.41
Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure. J Glaucoma (2008) 1.41
Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol (2009) 1.41
Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England. Drug Saf (2003) 1.40
Tdap vaccination during pregnancy to reduce pertussis infection in young infants. Can Fam Physician (2013) 1.40
Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov. J Clin Pharmacol (2013) 1.40
Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol (2012) 1.40
Influenza vaccination during pregnancy. Can Fam Physician (2002) 1.39
Electric shock during pregnancy. Can Fam Physician (2003) 1.39
Examining the health and drug exposures among Canadian children residing in drug-producing homes. J Pediatr (2011) 1.39
"Cardiac memory": a struggle against forgetting. Circ Res (2003) 1.39
Eating fish during pregnancy. Risk of exposure to toxic levels of methylmercury. Can Fam Physician (2002) 1.37
Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department. BMJ (2004) 1.35
Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol (2005) 1.35
Modulation of celecoxib pharmacokinetics by food in pediatric patients. Clin Pharmacol Ther (2005) 1.33
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ (2009) 1.32
Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician (2007) 1.29
Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ (2014) 1.28
The relationship between stress and hair cortisol in healthy pregnant women. Clin Invest Med (2007) 1.26
Systematic evaluation of errors occurring during the preparation of intravenous medication. CMAJ (2008) 1.26
Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol (2002) 1.25
Topical 4% amethocaine gel reduces the pain of subcutaneous measles-mumps-rubella vaccination. Pediatrics (2004) 1.25
Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use. Pharmacogenomics (2008) 1.24